Tumor Drug-Resistance: A Challengeto Therapists and Biologists
- 1 June 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 307 (6) , 438-444
- https://doi.org/10.1097/00000441-199406000-00011
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Modulation of multidrug-resistant multiple myeloma by cyclosporinThe Lancet, 1992
- Depletion of Glutathione in Normal and Malignant Human Cells In Vivo by Buthionine Sulfoximine: Clinical and Biochemical ResultsJNCI Journal of the National Cancer Institute, 1992
- MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemiaBritish Journal of Haematology, 1990
- Sequence of mdr3 cDNA encoding a human P-glycoproteinGene, 1988
- Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteinsCell, 1986
- Amplification and Expression of Genes Associated with Multidrug Resistance in Mammalian CellsScience, 1986
- Variable bioavailability following repeated oral doses of etoposideEuropean Journal of Cancer and Clinical Oncology, 1985
- Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cellsNature, 1984
- Variable Bioavailability of Oral MercaptopurineNew England Journal of Medicine, 1983
- Metaphase Chromosome Anomaly: Association with Drug Resistance and Cell-Specific ProductsScience, 1976